Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 2

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 2
---
 and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. PRELIMINARY PROXY STATEMENT/PROSPECTUS SUBJECT TO COMPLETION, DATED JANUARY 23, 2025 PROXY STATEMENT FOR THE SPECIAL MEETING OF BELLEVUE LIFE SCIENCES ACQUISITION CORP.
AND
PROSPECTUS FOR [ • ] SHARES OF COMMON STOCK OF BELLEVUE LIFE SCIENCES ACQUISITION CORP. _______________________________________ To the Stockholders of Bellevue Life Sciences Acquisition Corp.: You are cordially invited to attend the special meeting of Bellevue Life Sciences Acquisition Corp., a Delaware corporation (“ BLAC”), at 10:00 a.m. Eastern Time, on February13, 2025 at 10900 NE 4 thStreet, Suite 2300, Bellevue, WA 98004, or at such other time, on such other date to which the meeting may be adjourned or postponed (the “Special Meeting”). At the Special Meeting, BLAC stockholders will be asked to consider and vote upon a proposal, which is referred to herein as the “ Business Combination Proposal” to approve and adopt the business combination reflected by the Amended and Restated Business Combination Agreement dated as of May 23, 2024, as amended on December 20, 2024 (as may be amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement”), copies of which are attached to the accompanying proxy statement/prospectus as Annex A and Annex B, respectively, by and among BLAC, OSR Holdings Co., Ltd., a corporation organized under the laws of the Republic of Korea (“ OSR Holdings”), each stockholder of OSR Holdings that executes a Participating Stockholder Joinder thereto (each such person, a “ Participating Company Stockholder”), and each stockholder of OSR Holdings that executes a Non -ParticipatingStockholder Joinder thereto (each such person, a “ Non-Participating Company Stockholder”, and together with the Participating Company Stockholders, the “ OSR Holdings Stockholders”), and certain related documents. The Participating Company Joinder and the Non -ParticipatingJoinder are referred to collectively as a “Joinder” to the Business Combination Agreement. As further described in the accompanying proxy statement/prospectus, subject to the terms and conditions of the Business Combination Agreement, the following transactions will occur (collectively, the